ArticleThe international journal of cardiovascular imaging2017
Epicardial adipose tissue is associated with high-risk plaque feature progression in non-culprit lesions.
Article in The international journal of cardiovascular imaging, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Current status and mechanistic insights into nontarget coronary lesions in patients with diabetes and early abnormal glucose metabolism.World journal of diabetes · 2025Review
- Quantification of epicardial fat volume using low-dose cardiac scan in patients with low calcium score.Quantitative imaging in medicine and surgery · 2023Article
- Influence of LDL-Cholesterol Lowering on Coronary Plaque Progression of Non-Target Lesions in Patients Undergoing Percutaneous Coronary Intervention: Findings from a Retrospective Study.Journal of clinical medicine · 2023Article
- Lipoprotein(a) is associated with coronary atheroma progression: analysis from a serial coronary computed tomography angiography study.Journal of geriatric cardiology : JGC · 2021Article
- Dual-layer spectral detector CT to study the correlation between pericoronary adipose tissue and coronary artery stenosis.Journal of cardiothoracic surgery · 2021Article
- Deleterious Effects of Epicardial Adipose Tissue Volume on Global Longitudinal Strain in Patients With Preserved Left Ventricular Ejection Fraction.Frontiers in cardiovascular medicine · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Several studies have suggested a link between epicardial adipose tissue (EAT) volume and high-risk plaques (HRPs); however, little is known about the association between EAT volume and HRP progression in non-culprit lesions (NCLs). Therefore, we evaluated whether EAT can independently predict HRP characteristic progression in NCLs by coronary computed tomography angiography (CCTA). In this single-centre trial, we analysed 131 consecutive patients (median age 61 years, male 72.52%) undergoing CCTA with percutaneous coronary intervention (PCI) for culprit lesions. All patients were scheduled to undergo follow-up CCTA 12 months after PCI. HRP features, including positive remodelling, low attenuation plaque, spotty calcification, and napkin-ring sign, along with EAT volume, were assessed by CCTA. The numbers of HRP features were compared between baseline and follow-up CCTA to detect HRP progression in NCLs, and patients were classified into two groups based on HRP progression. Logistic regression analysis was used to evaluate whether EAT volume was independently associated with HRP progression in NCLs. Overall, 23 of 131 patients who underwent two CCTAs exhibited HRP progression in NCLs (17.6%). Logistic regression analysis showed that a higher baseline EAT volume was associated with NCL HRP progression (odds ratio 1.019, 95% confidence interval 1.009-1.029, P < 0.001). The cut-off value for baseline EAT volume for NCL HRP progression was 107 ml based on receiver-operator characteristic curve analyses, and the area under the curve was 0.66. Baseline EAT volume was identified as an independent predictor of NCL HRP progression.
Indexed as
Identifiers
28550587What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.